Myeloma clinical trials are both a treatment option for all types of patients and the core way that new advances are made in myeloma care. Learn more about these clinical trials.
Nanjing Leads Biolabs is starting a new clinical trial for a myeloma bi-specific antibody targeting GPRC5D.
Roswell Park Cancer Institute investigates changes in myeloma patients' immune cell subsets after non-chemo interventions.
Dr. Gunjan L. Shah and her team at MSK in NY are conducting a clinical trial to reverse T-cell exhaustion by pairing antioxidants alongside CAR T-cell therapy.
The main goal of the study is to find out if non-chemotherapeutic interventions can improve the immune system and quality of life in people with myeloma.
Does sleep apnea cause myeloma to progress? This clinical trial will help us learn more.
The UNC invites patients and caregivers to help them understand what factors affect patients' physical/mental health and quality of life.
This study evaluates if the addition of isatuximab to the triple combination elotuzumab, pomalidomide and dexamethasone leads to improved response rates.
A clinical trial at MSKCC is open to determine if a new agent can enhance PET scans for better myeloma detection.L.
A study to understand how best to use daratumumab in newly diagnosed older myeloma patients.
A new bispecific antibody called elranatamab is being tested in studies for relapsed and refractory myeloma patients